[BostonCard]

Remember, all these interactions have so far only been observed in monkey cells in petri dishes.

I am happy that investigators are pursuing drug repurposing studies.  Evaluating drugs that have already been approved and have a well known safety record is much easier than finding a drug that targets SARS-CoV2 de novo, or even adapting a drug (like remdisivir) that is not yet approved.  However, I think it is important to point out that the world is littered with great sounding drug repurposing articles that, when tested clinically in humans, did not pan out.  As with everything else, this is more about more "shots on goal" than expecting any one of these to pan out, or even that any of them pan out.

BC

[BostonCard]

Remember, all these interactions have so far only been observed in monkey cells in petri dishes.

I am happy that investigators are pursuing drug repurposing studies.  Evaluating drugs that have already been approved and have a well known safety record is much easier than finding a drug that targets SARS-CoV2 de novo, or even adapting a drug (like remdisivir) that is not yet approved.  However, I think it is important to point out that the world is littered with great sounding drug repurposing articles that, when tested clinically in humans, did not pan out.  As with everything else, this is more about more "shots on goal" than expecting any one of these to pan out, or even that any of them pan out.

BC